SS
CMPX icon

Steve Schonfeld’s Compass Therapeutics CMPX Stock Holding History

Steve Schonfeld’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$202K Sell
92,227
-983,777
-91% -$2.9M ﹤0.01% 2193
2026
Q1 		$5.69M Buy
1,076,004
+623,562
+138% +$3.6M 0.04% 450
2025
Q4 		$2.43M Sell
452,442
-23,849
-5% -$110K 0.01% 802
2025
Q3 		$1.67M Buy
+476,291
New +$1.5M 0.01% 1131
2023
Q2 		– Sell
-14,127
Closed -$46.2K – 2187
2023
Q1 		$46.2K Buy
+14,127
New +$55.5K ﹤0.01% 1777

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Steve Schonfeld's CMPX Position: Q2 2026 in Review

Steve Schonfeld reduced its Compass Therapeutics (CMPX) stake by 91% in Q2 2026, selling an estimated $2.9M and leaving 92,227 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #2193.

Steve Schonfeld first reported a position in CMPX in Q1 2023 and has held it in 5 quarters since. The position peaked at $5.69M in Q1 2026. 213 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Steve Schonfeld held 92,227 shares of Compass Therapeutics worth $202K as of Q2 2026.
  • Steve Schonfeld sold 983,777 Compass Therapeutics shares in Q2 2026, an estimated $2.9M.
  • Compass Therapeutics made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #2193 holding.
  • Steve Schonfeld first reported a position in Compass Therapeutics in Q1 2023 and has held it in 5 quarters since.
  • Steve Schonfeld's Compass Therapeutics position peaked at $5.69M in Q1 2026.
  • 213 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.